Although increased transcriptional output is canonically associated with increased expression of transcription factors, both MYC and AR show evidence of rewiring or reprogramming upon progression of primary PCa to advanced disease, especially in the context of hormonal therapies used for treating recurrent PCa [10]. Here, AR is linked to posterior cortical atrophy.